Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 222

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 222
---
 of its subsidiaries, which will be subject to clause (i) of this definition) that would result in a loss, in the aggregate, of more than $20,000,000 of revenue generated by Clearwater and its subsidiaries (taken as a whole) between (and inclusive of) January 1, 2024 and December 31, 2024. In addition, the obligation of Enfusion to consummate the Merger is subject to the satisfaction or waiver by Enfusion of each of the following additional conditions:

| • |     | the representations and warranties of the Buyer Parties relating to certain aspects of Buyer Parties’                                                                                                                                                
 corporate existence and power, corporate authorization, capitalization, brokers’ fees and anti-takeover provisions being true and correct in all material respects on the Closing Date as if made on the Closing Date (except to the extent that any 
 such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty being true and correct in all material respects only as of such earlier date) after disregarding all “materiality,”          
 “Clearwater Material Adverse Effect” and similar qualifications;                                                                                                                                                                                     |

| • |     | the representations and warranties of Buyer Parties relating to absence of changes being true and correct in all 
 respects on the Closing Date as if made on the Closing Date;                                                     |

| • |     | the other representations and warranties of Buyer Parties being true and correct on the Closing Date as if made                                                                                                                                     
 on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct only as of such earlier date), except where the 
 failure of such representations and warranties to be so true and correct (disregarding all qualifications or limitations as to “materiality,” “Clearwater Material Adverse Effect” or words of similar import) would not,                           
 individually or in the aggregate, have a Clearwater Material Adverse Effect;                                                                                                                                                                        |

| • |     | the Buyer Parties having each have performed or complied in all material respects with all obligations required 
 to be performed or complied with by it under the Merger Agreement at or prior to the Closing;                   |

141

| • |     | the receipt by Enfusion of a certificate of Clearwater, signed on behalf of Clearwater by an authorized officer                      
 of Clearwater, certifying that the foregoing conditions to the obligations of Enfusion to effect the Merger have been satisfied; and |

Efforts to